FDA Authorizes TessArae's RM-Flu Chip for Emergency H1N1 Testing

By obtaining emergency use authorization from the FDA, Potomac Falls, Va.-based TessArae becomes the first array firm to have received an EUA to sell chips for the monitoring and early diagnosis of the H1N1 influenza A virus.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.